ARCH-al­lied AN Ven­ture Part­ners rais­es $200M to build biotechs out of re­search from Japan

A new in­vest­ment firm af­fil­i­at­ed with ARCH Ven­ture Part­ners has raised $200 mil­lion for its first fund as it seeks to back sci­en­tif­ic re­search out of Japan to cre­ate new glob­al biotech star­tups.

AN Ven­ture Part­ners’ fi­nanc­ing haul was dis­closed in a Thurs­day SEC fil­ing and comes the same week Os­a­ka-based drug­mak­er Ono Phar­ma­ceu­ti­cal said it had dou­bled its own cor­po­rate VC arm to $200 mil­lion af­ter hav­ing al­ready backed 11 star­tups, in­clud­ing Pho­tys Ther­a­peu­tics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA